FR2893847B1 - Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse - Google Patents

Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse

Info

Publication number
FR2893847B1
FR2893847B1 FR0512175A FR0512175A FR2893847B1 FR 2893847 B1 FR2893847 B1 FR 2893847B1 FR 0512175 A FR0512175 A FR 0512175A FR 0512175 A FR0512175 A FR 0512175A FR 2893847 B1 FR2893847 B1 FR 2893847B1
Authority
FR
France
Prior art keywords
vitamin
derivative
oily phase
spray composition
spray
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0512175A
Other languages
English (en)
Other versions
FR2893847A1 (fr
Inventor
Nathalie Willcox
Sandrine Orsoni
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Galderma SA
Original Assignee
Galderma SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galderma SA filed Critical Galderma SA
Priority to FR0512175A priority Critical patent/FR2893847B1/fr
Priority to EP06842071A priority patent/EP1957167A1/fr
Priority to PCT/FR2006/051260 priority patent/WO2007063255A1/fr
Publication of FR2893847A1 publication Critical patent/FR2893847A1/fr
Priority to US12/129,201 priority patent/US20080293681A1/en
Application granted granted Critical
Publication of FR2893847B1 publication Critical patent/FR2893847B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/59Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/12Aerosols; Foams
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
FR0512175A 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse Expired - Fee Related FR2893847B1 (fr)

Priority Applications (4)

Application Number Priority Date Filing Date Title
FR0512175A FR2893847B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
EP06842071A EP1957167A1 (fr) 2005-11-30 2006-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
PCT/FR2006/051260 WO2007063255A1 (fr) 2005-11-30 2006-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
US12/129,201 US20080293681A1 (en) 2005-11-30 2008-05-29 Sprayable pharmaceutical compositions comprising a vitamin d derivative and an oily phase

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0512175A FR2893847B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse

Publications (2)

Publication Number Publication Date
FR2893847A1 FR2893847A1 (fr) 2007-06-01
FR2893847B1 true FR2893847B1 (fr) 2010-10-29

Family

ID=36215730

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0512175A Expired - Fee Related FR2893847B1 (fr) 2005-11-30 2005-11-30 Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse

Country Status (4)

Country Link
US (1) US20080293681A1 (fr)
EP (1) EP1957167A1 (fr)
FR (1) FR2893847B1 (fr)
WO (1) WO2007063255A1 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8263580B2 (en) 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
CA2611147C (fr) 2005-06-01 2013-04-09 Stiefel Research Australia Pty Ltd. Formulation d'emulsion topique
US9254296B2 (en) 2009-12-22 2016-02-09 Leo Pharma A/S Pharmaceutical composition comprising vitamin D analogue and cosolvent-surfactant mixture
BR112012015447A2 (pt) * 2009-12-22 2016-03-15 Leo Pharma As composição tópica para aplicação cutânea
JP5712010B2 (ja) * 2010-03-24 2015-05-07 第一三共ヘルスケア株式会社 ビタミンd類が安定化された化粧用又は医薬用外用組成物
ES2491693T3 (es) 2010-06-25 2014-09-08 G. Pohl-Boskamp Gmbh & Co. Kg Agente para el tratamiento de afecciones de la piel
RU2602171C2 (ru) * 2011-03-24 2016-11-10 Лео Фарма А/С Композиция, содержащая липидные наночастицы и кортикостероид или производное витамина d
WO2013150386A2 (fr) * 2012-04-04 2013-10-10 Pronova Biopharma Norge As Compositions comprenant des acides gras oméga-3 et de la vitamine d destinées à lutter contre l'acné vulgaire et/ou l'eczéma, et méthodes et utilisations associées

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
EP0215956A4 (fr) * 1985-03-14 1988-09-07 Chugai Pharmaceutical Co Ltd Composition de traitement de dermatoses.
JPS63255229A (ja) * 1987-04-14 1988-10-21 Toyo Jozo Co Ltd 活性型ビタミンd類の硬カプセル製剤
JPH0525049A (ja) * 1990-06-21 1993-02-02 Tokai Capsule Kk 安定な1α―ヒドロキシビタミンD類製剤
US6538039B2 (en) * 1994-04-29 2003-03-25 Laboratoire L. Lafon Pharmaceutical dosage form for transdermal administration
TW422696B (en) * 1995-03-20 2001-02-21 Katsuhiko Mukai Ophthalmic composition containing active vitamin D
EP0897300A4 (fr) * 1995-10-10 2000-07-05 Marilyn Strube Traitement du prurit a l'aide de vitamine d et d'analogues de celle-ci
NZ500769A (en) * 1998-03-04 2001-04-27 Teijin Ltd Activated dihydroxy- and hydroxyvitamin D3 emulsion-type lotions for treating psoriasis
FR2862540B1 (fr) * 2003-11-21 2007-03-30 Galderma Res & Dev Composition sous forme de spray comprenant un actif pharmaceutique, au moins un silicone volatile et une phase non polaire non volatile

Also Published As

Publication number Publication date
EP1957167A1 (fr) 2008-08-20
US20080293681A1 (en) 2008-11-27
WO2007063255A1 (fr) 2007-06-07
FR2893847A1 (fr) 2007-06-01

Similar Documents

Publication Publication Date Title
FR2893845B1 (fr) Composition sous forme de spray comprenant un corticoide et une phase huileuse
FR2893847B1 (fr) Composition sous forme de spray comprenant un derive de vitamine d et une phase huileuse
FR2909284B1 (fr) Nouvelles compositions sous forme d'onguent sans vaseline comprenant un derive de vitamine d et eventuellement un anti-inflammatoire steroidien
FR2871698B1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques et une phase huileuse
PL1917072T3 (pl) Formulacja witaminowa
IL176014A0 (en) Azepinoindole derivatives as pharmaceutical agents
MA28686B1 (fr) Derives de pyrrolopyridine
IL180630A0 (en) Pyrrole derivatives as pharmaceutical agents
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
DE602004025558D1 (de) Federbeingleitlager
EP1704848A4 (fr) Composition demaquillante huileuse
HK1112179A1 (en) Oily cosmetic preparation
ATE453384T1 (de) Neue dosierformulierung
PL1863458T3 (pl) Układ rozpuszczalników do zwiększania rozpuszczalności środków farmaceutycznych
ITMI20031570A1 (it) Composizione per uso dietetico, farmaceutico o cosmetico
EP1776112A4 (fr) Composes heterocycliques comme agents pharmaceutiques
FR2871700B1 (fr) Composition sous forme de spray comprenant une association d'actifs pharmaceutiques, une phase alcoolique, et une phase huileuse
EP1889613A4 (fr) Composition pharmaceutique comprenant de la vitamine k
DE602005017152D1 (de) Neue 2,6-diaminopyridin-3-on-derivate
GB0423800D0 (en) New pharmaceutical formulations
FR2881048B1 (fr) Composition parfumante sous forme compactee
FR2895673B1 (fr) Composition cosmetique comprenant une huile
MA28557B1 (fr) Compositions pharmaceutiques sechees par pulverisation
AP1994A (en) An antimycobacterial pharmaceutical composition
ITRM20050521A1 (it) Composizione a base di vitamine k e d per la prevenzione e il trattamento dell'osteoporosi.

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120731